Emergency department visits by children and adolescents for antipsychotic drug adverse events

JAMA Psychiatry. 2015 Mar;72(3):292-4. doi: 10.1001/jamapsychiatry.2014.2412.

Authors

Lee M Hampton¹, Matthew Daubresse², Hsien-Yen Chang³, G Caleb Alexander², Daniel S Budnitz¹

Affiliations

¹ Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
² Center for Drug Safety and Effectiveness, Johns Hopkins University, Baltimore, Maryland.
³ Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

No abstract available

MeSH terms

Adolescent
Antipsychotic Agents / adverse effects*
Child
Drug-Related Side Effects and Adverse Reactions / epidemiology*
Emergency Service, Hospital / statistics & numerical data*
Female
Hospitalization / statistics & numerical data
Humans
Male
Product Surveillance, Postmarketing / statistics & numerical data
United States / epidemiology

Substances

Antipsychotic Agents

Grants and funding

CC999999/Intramural CDC HHS/United States